Tag: antidepressant use during pregnancy
Adam joins us to discuss what we do and don’t know about the effects of antidepressants on babies and mothers and the importance of counselling in order to aid families in making important decisions about pharmaceutical drug use.
After three randomized trials inclusive of only 247 women, and with side effects that include loss of consciousness, brexanolone has been approved for the treatment of postpartum depression. Because of the drug’s risk profile, women must receive the 60-hour infusion under medical supervision and “cannot function as her child(ren)’s primary caregiver.”
What depressed pregnant women need is compassionate care and accurate information that recognizes the potentially severe consequences of depression while making it clear that chemicals going into a baby throughout its development will likely have consequences for that development.
From The Baltimore Sun: Over time, studies have shown that antidepressants during pregnancy are linked with congenital defects as well as increased incidence of depression...
Adults in the U.S. diagnosed with “serious mental illness” die on average 25 years earlier than others. This is not controversial, as establishment psychiatry and its critics agree. What is controversial is who is to blame?
Although the drug industry, our drug regulators and leading psychiatrists have done what they could to obscure these facts, it can no longer be doubted that antidepressants are dangerous and can cause suicide and homicide at any age.
The judicial system and the public are becoming increasingly aware of the hazards of psychiatric drugs, including their capacity to make people behave in ways that are harmful to themselves and others, and contrary to their past behavior and character.
Antidepressant use during pregnancy has been associated with a number of fetal and developmental complications. The latest meta-analysis of the effect of SSRI antidepressants...
Children exposed to SSRIs during pregnancy, a recent study shows, were diagnosed with depression by age 14 at more than four times the rate of children whose mothers were diagnosed with a psychiatric disorder but did not take the medication. Such reports are usually met, appropriately, with an outpouring of reassurances from clinicians who take care of pregnant women, who need to protect their emotional wellbeing in whatever way they can. From my perspective as a pediatrician specializing in early childhood mental health our attention must be on prevention.
I have a complicated response to the article Panel Calls for Depression Screenings During and After Pregnancy, by Pam Belluck, in the January 26th New York Times, which calls for depression screening before and after pregnancy. On the face of it this sounds like a great idea - a public health measure to prevent or deal with problematic postpartum responses – baby blues, postpartum depression, postpartum psychosis.
According to the CDC, January is National Birth Defects Prevention Month. New research continues to link various SSRI antidepressants with birth defects and neurological abnormalities in newborns. The latest study to examine this topic, a meta-analysis led by Dr. Anick Bérard, found a 23% increased risk for birth defects, and a 28% increased risk for heart problems, in the infants of women who took the SSRI Paxil (paroxetine) during their first trimester.